Working… Menu

An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C))

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02623699
Recruitment Status : Completed
First Posted : December 8, 2015
Last Update Posted : July 26, 2021
Ionis Pharmaceuticals, Inc.
Information provided by (Responsible Party):